Small nucleic acid drugs have not been approved by investors...

Small nucleic acid drugs have not been approved by investors in the weight loss market, probably because their efficacy has not been fully verified. Shengnuo Pharmaceutical needs to further demonstrate the effectiveness of its drug STP705 in weight loss and fat shaping. Finding financing is critical to Sennuo's transition to the commercial stage, as it risks running out of cash flow.